Circulating Extracellular Vesicles for Early-disease Thernostics (CEVET)

Keyphrases

1. Exosomes 100%
2. Exosomal microRNA 72%
3. Single Vesicle 72%
4. Magnetic Nanoparticles 72%
5. DNA Nanodevice 72%
6. Enzyme-free 72%
7. Tumor 72%
8. MicroRNA 58%
9. Hybridization Chain Reaction 55%
10. DNAzyme 54%
11. Fluorescence Imaging 54%
12. Aptamer 50%
13. Early Diagnosis 47%
14. Microsampling 42%
15. Direct Visualization 42%
16. Direct Quantification 42%
17. RNA Exosome 42%
18. High Sensitivity 40%
19. Total Internal Reflection Fluorescence 39%
20. Cancer Cells 39%
21. Circulating Extracellular Vesicles 36%
22. Dual Therapy 36%
23. Treatment Monitoring 36%
24. Early Disease 36%
25. Total Internal Reflection 36%
26. MicroRNA Imaging 36%
27. Stoichiometric Analysis 36%
28. Immunosensor 36%
29. Magnetically Controlled 36%
30. Tumor-derived Extracellular Vesicles 36%
31. Scattering Sensor 36%
32. Dual Aptamer 36%
33. Transgenic Mouse Model 36%
34. Blood-brain Barrier 36%
35. Tumor Exosomes 36%
36. Neuropathology 36%
37. Alzheimer's Disease Brain 36%
38. Early Alzheimer's Disease 36%
39. Imaging Tools 36%
40. Near-infrared Imaging 36%
41. Contrast Agent 36%
42. Superparamagnetic Iron Oxide Nanoparticles (SPIONs) 36%
43. Specific Probe 36%
44. Anti-Alzheimer Drugs 36%
45. NIR-II Fluorophores 36%
46. Alzheimer's Disease Detection 36%
47. Dual-modal Nanoprobe 36%
48. Dual-modal Imaging 36%
49. Brain Imaging 36%
50. Positron Emission Tomography 36%
51. APPPS1 36%
52. Extracellular Deposits 36%
53. Low Spatial Resolution 36%
54. Imaging Magnetic Resonance 36%
55. Alzheimer's Disease Diagnosis 36%
56. Magnetic Resonance Imaging Contrast Agents 36%
57. Sandwich Structure 36%
58. High Spatial Resolution 36%
59. Highly Selective 36%
60. Molecular Recognition 36%
61. Dual-modal 36%
62. High Efficiency 36%
63. Magnetic Resonance Imaging 36%
64. Gold Nanoparticles 36%
65. Early Detection 36%
66. Neuroprotective Effect 36%
67. Mn2+ 36%
68. Nanostructures 36%
69. Messenger RNA (mRNA) 36%
70. Cyanine Fluorophores 36%
71. Cardiac Troponin 36%
72. Non-radial 36%
73. Living Cells 36%
74. Probe-based 36%
75. High-throughput Detection 36%
76. Nanoparticle-free 36%
77. Cyanine 36%
78. Photodynamic Therapy 36%
79. Nanomaterials 36%
80. In Situ 36%
81. Turn-on Fluorescence 36%
82. High Selectivity 36%
83. Nanoprobe 36%
84. Cardiac Biomarkers 36%
85. Recognition-based 36%
86. Target-triggered 36%
87. Surface-enhanced Raman Scattering 36%
88. Photodynamic 36%
89. Neuroprotective 36%
90. Gene Silencing 36%
91. Immunomagnetic 36%
92. Fluorometric Assay 36%
93. Thrombin 36%
94. Low Abundance 36%
95. Disease Progression 36%
96. Induced Toxicity 36%
97. Imaging Probe 36%
98. Carcinoembryonic Antigen 36%
99. Senile Plaques 36%
100. Glutathione 36%
101. Amyloid Plaques 36%
102. Extracellular Vesicles 32%
103. RNA Imaging 24%
104. Functionalized Magnetic Nanoparticles 21%
105. Human Serum 19%
106. Serum Samples 19%
107. Gene Silencing Therapy 18%
108. Honeycomb MnO2 18%
109. MicroRNA-21 (miR-21) 18%
110. Mn2+ Ions 18%
111. Imaging Assay 18%
112. In Cancer 18%
113. Catalase 18%
114. Aptamer Probe 18%
115. Cancer Patients 18%
116. Bodily Fluids 15%
117. Disease-associated 15%
118. Fluorescence Assay 15%
119. Tumor Progression 15%
120. Capture DNA 14%
121. Myocardial Infraction 14%
122. Treatment Efficacy 14%
123. Detection Device 14%
124. YOYO-1 14%
125. Reaction Products 14%
126. Fluorescent Indicator 13%
127. Sensitive Sensor 12%
128. Enhanced Raman 12%
129. Simple Sensor 12%
130. Cancer Serum 12%
131. Enzyme Amplification 12%
132. Stoichiometry 12%
133. Culture Media 12%
134. Raman Signal 12%
135. Diluted Human Serum 12%
136. Self-assembly 12%
137. Cell Samples 12%
138. Signal Probe 12%
139. Biomarker Quantification 11%
140. Cell-cell Communication 10%
141. Disease Diagnosis 10%
142. Enhanced Photodynamic Therapy 9%
143. Folate 9%
144. O2 Supply 9%
145. Multifunctional Hybrids 9%
146. Self-sufficiency 9%
147. Tumor Hypoxia 9%
148. Self-generated 9%
149. Disintegration 9%
150. In Situ Assembly 9%
151. Response to Therapy 9%
152. Exosome Biomarker 9%
153. Enhanced Fluorescence 9%
154. Exosome Detection 9%
155. Ultrasensitive Assay 9%
156. Protein Kinase 9%
157. Diagnostic Biomarker 9%
158. Nanocarriers 9%
159. Detection Sensitivity 9%
160. Hydrogen Peroxide 9%
161. Singlet Oxygen 9%
162. Therapeutic Efficacy 9%
163. Therapy Efficacy 9%
164. Cancer Development 9%
165. GSH Level 9%
166. Specific Antibodies 9%
167. Specific Binding 9%
168. Early Response 9%
169. Flow Cell 9%
170. Reactive Oxygen Species 9%
171. Control Subjects 9%
172. Tyrosine Kinase 9%
173. Cancer Treatment 9%
174. Metastasis 9%
175. Inflammation 8%
176. Nucleic Acids 8%
177. Body Fluids 8%
178. Surface Proteins 8%
179. Secondary Antibody 7%
180. Cancer-associated Proteins 7%
181. Commercial ELISA Kit 7%
182. Thrombin Concentration 7%
183. Low Limit of Detection 7%
184. Thrombin Binding Aptamer 7%
185. Pre-purification 7%
186. SiO2 Nanoparticles 7%
187. Magnetic Silica 7%
188. Fluorescence Signal Intensity 7%
189. Early Intervention 7%
190. Emergent Nature 7%
191. Silica-coated Magnetic Nanoparticles 7%
192. Capture Method 7%
193. Nanocomplex 7%
194. Treatment Survival 7%
195. Target Capturing 7%
196. Acute Myocardial Infraction 7%
197. High Specificity 7%
198. Fluorescence Measurement 7%
199. Antibody Conjugates 7%
200. Fluorescent Dye 7%